Showing posts with label BECERRA. Show all posts
Showing posts with label BECERRA. Show all posts

Saturday, April 17, 2021

POLITICO NIGHTLY: Welcome to the new era of vaccines

 


 
POLITICO Nightly logo

BY JOANNE KENEN

Presented by

With help from Renuka Rayasam

MRNA IS HERE TO STAY — The new mRNA vaccines for Covid-19 aren’t just the pathway out of this particular virus or even its variants. They open the door to a whole new approach to immunizations.

Vaccinologists are jazzed. The rest of us should be too.

“That new era is already here,” according to Wayne Koff, president and CEO of the Human Vaccines Project.

The mRNA vaccines for Covid took on even more importance this week amid concern over possible links to rare blood clots with the Johnson & Johnson and AstraZeneca vaccines.

To get a layperson’s glimpse into this new world, Nightly spoke, separately, to two top scientists — Koff, and Barton Haynes, director of the Duke Human Vaccine Institute and the Center for HIV-AIDS Vaccine.

Let’s make a few things clear right away. First, the Covid vaccines were developed with amazing speed — less than a year, when vaccine development would more normally take a decade or so. But much of the underlying basic scientific work had been done years earlier, both on messenger RNA and on understanding coronaviruses, after the SARS outbreak in 2003, and MERS in 2012. So while the pandemic work was super-duper fast, it wasn’t out of the blue. (That’s our vaccine-safety-plug of the day.)

Second, while Koff, Haynes and other scientists are very excited about how the mRNA breakthrough could lead to new vaccines for tough diseases like malaria, HIV and flu it’s not going to happen next week. (When you see a headline about a successful experiment on a bunch of mice — remember, you are not a mouse.)

Which doesn’t mean breakthroughs won’t come. There are already interesting advances, new ideas, new approaches, including on how to elicit broadly neutralizing antibodies (bnAbs) for HIV.

A member of the Bundeswehr assists in preparing trays of syringes filled with the Pfizer/BioNTech vaccine against Covid-19 at the Arena Berlin mass vaccination center in Germany.

A member of the Bundeswehr assists in preparing trays of syringes filled with the Pfizer/BioNTech vaccine against Covid-19 at the Arena Berlin mass vaccination center in Germany. | Getty Images

But the reason scientists are so excited is bigger than the mRNA platform. That’s crucial of course, but it’s one of several “converging leaps” in technology and knowledge, the others being computational biology, artificial intelligence and machine learning. “That has unquestionably put us in a position to transform human health,” Koff told Nightly.

“We have the ability to look at huge sets of data in ways that we had never been able to do before,” he said. “What we’re trying to do here is understand the immune system in the way the genome project sequenced the genome a couple of decades ago.” (That was 2003, to be precise.)

Both Koff and Haynes are HIV vaccine veterans. In comparison, the novel coronavirus — with all its variants, with all the strange and variable ways that Covid-19 manifests as a disease — is a relatively easy target for a vaccine-maker. HIV in contrast, is one of the “fastest evolving life forms on earth,” said Haynes. “Covid is slow in comparison.” The coronavirus that causes our current pandemic could also have been an even more efficient, more deadly killer. In other words, even though it’s really, really bad, it could have been worse.

But even if we are “on the brink of a golden age,” as Koff put it, there are caveats aplenty. Messenger RNA vaccines provide “a platform that has great potential, it’s flexible, it’s fast.” But there are still challenges in finding the right target (the antigen), eliciting the right immunological response, making sure it works broadly in the population, and that the protection endures. We’ve done it with smallpox and yellow fever and polio and measles. But not with HIV, TB, malaria — and not particularly effectively with the flu.

Haynes, who has been working with mRNA tech for four years already, says the HIV virus is particularly challenging because the body doesn’t want to make the antibodies. The virus basically inserts itself into the cells of the person it infects — and then it hides. “Scientists have to figure out how to coax it into responding — and even unraveling that took about 15 years.” When a vaccine is finally achieved, “it will be a very complex vaccine.”

His institute is working on other diseases, including coming up with a “universal” or at least broad flu vaccine, a sort of holy grail for vaccine researchers, effective against multiple flu strains (including the ones that give epidemiologists nightmares and the ones that don’t yet exist that give them even worse nightmares.) The mRNA is promising here. These kinds of shots are easy to manufacture, and can mix different elements, like the flu itself does. And from what we know so far about the first two coronavirus shots, the immune response looks both strong and durable.

So in addition to a “universal flu,” shot, scientists are also aiming for a “pan-coronavirus” vaccine. That would protect not just against the virus the whole world is combatting now but a whole lot of related ones, living in bats but capable of jumping to humans. And they could be more contagious and/or more lethal than the one we’re now fighting. The threat is broad and real.

“There are hundreds of thousands of various viruses out there,” Haynes said. They need to be studied and sampled “to figure out what is out there” and what we should be preparing for. But with mRNA, once a virus does hit, a vaccine can be made quickly — even faster than the 10 months or so it took to make the first Pfizer/BioNTech and Moderna shots. Maybe, he said, as little as 60 days. Imagine if we had a shot last March, not last November. Speed like that, Haynes said, could mean the difference between a manageable outbreak and a raging pandemic.

The potential — whether for HIV or malaria or TB or Alzheimer's or universal flu or “Pan-corona” isn’t going to be realized just by hard work in labs. It will require sustained investment — investment that the scientists hope we’ll make after everything we’ve endured this year. “This has shut the world down, cost millions of lives, will have lingering effects,” Koff said. “If we can’t convince the key stakeholders that now is the time to put the pieces of pandemic preparedness into place, we never will. And that’s what we’re trying to do.”

Welcome to POLITICO Nightly. Reach out with news, tips and ideas for us at jkenen@politico.com and rrayasam@politico.com, or on Twitter at @joannekenen and @renurayasam.

A message from the SEIU:

President Biden is investing $400 billion in care workers — largely women of color & immigrants working on the frontlines of this pandemic. We have a once-in-a-generation opportunity to create millions of sustainable union care jobs of the future. It’s time for Congress to pass President Biden’s jobs plan! Learn more

 
FIRST IN NIGHTLY

‘STEEP LEARNING CURVE — Top White House officials have grown increasingly frustrated with Health Secretary Xavier Becerra over his department’s sluggish effort to house thousands of unaccompanied minors , as the administration grapples with a record number of children crossing the southern border, Adam CancrynSabrina Rodríguez and Anita Kumar write.

The dissatisfaction with Becerra centers on complaints he’s been slow to take charge of the response since his confirmation on March 18, according to eight current and former government officials and others familiar with the situation. The administration has scrambled to find new shelters and speed the vetting of adults to care for the children as thousands remain in packed detention facilities along the border.

Biden aides led by Domestic Policy chief Susan Rice and Amy Pope, a senior adviser on migration hired to help direct the administration’s border response, have pressed the health department in meetings over the past several weeks to pick up the pace, warning that the influx of unaccompanied children is only likely to accelerate into the spring and early summer.

But a month into Becerra’s tenure, officials working on the issue have privately questioned his preparedness for managing such a sprawling emergency — and his willingness to take ownership of a historically intractable and politically divisive problem.

“He did not fully appreciate the issue when he first came in,” said one senior administration official. “It’s been a steep learning curve for him.”

 

SUBSCRIBE TO "THE RECAST" TO JOIN AN IMPORTANT CONVERSATION: Power is changing, in Washington and across the country. More people are demanding a seat at the table, insisting that all politics is personal and not all policy is equitable. Our twice-weekly newsletter "The Recast” breaks down how race and identity are shaping politics and policy in America and we are recasting how we report on it. Get fresh insights, scoops and dispatches on this crucial intersection from across the country and hear from important new voices that challenge business as usual. Don't miss out, SUBSCRIBE . Thank you to our sponsor, Intel.

 
 
WHAT'D I MISS?

— Biden to raise Trump’s refugee cap after blowback: The Biden administration this afternoon said it will raise the refugee cap by mid-May , a move that comes after swift backlash over an earlier announcement that it would keep in place the current historically low cap set by former President Donald Trump.

— Mesh mask lands Capitol riot defendant in hot water with judge: A federal judge is demanding that a Pennsylvania woman arrested for her alleged role in the Capitol riot, Rachel Powell, explain why a video of her circulating online shows her wearing a porous, mesh mask despite another judge’s order to comply with Covid mask requirements while she awaits trial.

— Greta Thunberg to testify in Congress on Earth Day: Teenage Swedish climate activist Greta Thunberg will testify before Congress at an Earth Day hearing on Thursday, the same day that Biden will convene world leaders for a virtual conference on climate change.

— Biden renews calls for gun reform after Indianapolis shooting: The mass shooting at a FedEx facility Thursday night left eight people dead and follows mass shootings last month in Atlanta and Boulder, Colo. It was at least the third mass shooting in the city this year, Indianapolis officials said at a press conference today.

 

A message from the SEIU:

Advertisement Image 

 
ASK THE AUDIENCE

Nightly asked you: If you have been working remotely since the pandemic began last year, have you visited your office even once? Tell us what it was like. Your select, lightly edited responses are below:

“I’ve been to my office exactly once since March 10, 2020. On Aug. 12, I signed up for a two-hour slot and spent all of five minutes inside. My only goal was to grab some notebooks and my office chair (and my back thanks me profusely for that; I shudder to think the physical state I’d be in if I hadn’t gotten a proper place to sit for WFH). It was eerie and quiet, very dystopian. We’re not fully reopening until September, so by the time I’m back, it will have been more than a year since my one visit. I find it very hard to picture what going back will be like.” — Seth Michaels, nonprofit communications, Washington, D.C.

“We have a big, bright, colorful loft space for more than 100 people that we moved into six months before the pandemic started. Maybe three to five of us have been coming since July. So we have the run of the place. We’ve moved furniture, we move between conference rooms on a whim — whatever suits us that day. I bring my two dogs — Buttercup and Pablo — and they have a blast, chasing each other, tennis balls, exploring. All that said, I’d prefer to see my colleagues.” — Nicholas Turner, executive director, Brooklyn, N.Y.

“We sent people home in mid-March 2020. In July I stopped in to check on the office. It was like being in a post-apocalyptic fiction movie. Files left on desks, wall calendars open to March 2020, silence instead of meeting banter. It was very sad. It’s April 2021. I try to be in the office at least once a week, but it just feels empty and unnecessary. I’m retiring in June and am missing being closer to my colleagues. Even though we communicate well remotely, the small kindnesses and moments of unexpected laughter are gone.” — Wendy Northcross, CEO, Cape Cod, Mass.

“Walked back into my classroom for the first time in a year last week. We will return to in-person instruction next week. A flood of emotion ran through my head and heart, flashing back to the final day last March when they said ‘two weeks!’ We laughed back then, thinking a month at least. A whole year. No one's laughing now. The kids are shattered. So are we. Yeah, a flood of emotion ran through my head and heart. Time to start life again.” — Brent Smiley, middle school teacher, Los Angeles

“I went back to my office once. As planned, no one else in my department was there at the same time. To get into the building, I had to go through underground walkways from a nearby building. When I unlocked the door, everything, even an old New York Times, was as I left it. I only stayed an hour. Being by myself in a big building felt a little too Halloween 15.” — Jill Abramson, Harvard senior lecturer, Cambridge, Mass.

AROUND THE NATION

PA DEMS’ BIG DILEMMA — With tattoos and the looks of a WWE body double, Pennsylvania Lt. Gov. John Fetterman isn’t your average politician. He says that will help win over working class Trump voters in his bid to flip an open Senate seat in 2022, but he’s facing resistance from fellow Democrats who think the party should pick the most progressive candidate possible — not another white man with Rust Belt appeal. In the latest POLITICO Magazine cover story and in POLITICO DispatchHolly Otterbein reports on how the race has become an inflection point in the party.

Play audio

Listen to the latest POLITICO Dispatch podcast

PUNCHLINES

‘HEY! IT’S THE WEEKEND!’ — Matt Wuerker is outside in D.C.’s spring splendor for his Weekend Wrap , smelling the flowers and bringing us the latest in political cartoons and satire, including the departure of U.S. troops from Afghanistan, the fight against Covid variants and the multiple police shootings rocking communities around the country.

Nightly video player of Matt Wuerker's Weekend Wrap

NIGHTLY NUMBER

$10 million

The amount Liberty University is seeking in a lawsuit filed against Jerry Falwell Jr. , accusing its former president of breaching his contract and fiduciary duty to the Christian school that has been engulfed in scandal over his personal behavior.

 

YOUR GUIDE TO THE BIDEN ADMINISTRATION: As the Biden administration closes in on three months in office, what are the big takeaways? Will polls that show support for infrastructure initiatives and other agenda items translate into Republican votes or are they a mirage? What's the plan to deal with Sen. Joe Manchin? Add Transition Playbook to your daily reads for details you won't find anywhere else that reveal what's really happening inside the West Wing and across the executive branch. Track the people, policies and power centers of the Biden administration. Subscribe today.

 
 
PARTING WORDS

THE WOMAN WHO’S FOOLED YOU ON TWITTER — Comedian Blaire Erskine’s Twitter videos have made fools not just of the people she parodies, but also those who believe the characters she inhabits are real. That second list is one that includes filmmaker Michael Moore, journalist Katie Couric and yours truly, writes Nightly’s Renuka Rayasam. Moore and Couric believed one of her early viral skits impersonating a Trump supporter left stranded at an Omaha, Neb., rally. Your Nightly author won’t reveal which video fooled her because it’s, well, embarrassing.

Erskine’s rise is an only-in-the-pandemic tale of someone who parlayed viral videos she created from her Atlanta apartment into actual, that is paid, comedy writing jobs in less than a year. It’s also a story about making comedy in the age of deep political polarization.

“Lots of challenges,” Erskine told Nightly about political comedy. She’s careful not to spend too much time skewering radical ideologues because she doesn’t want to give them a bigger platform. She also admits that liberal-leaning comedians, like herself, struggle to mock Democrats.

“We are also doing dumb stuff every day,” she said, “stuff that deserves to be talked about.”

Despite the challenges, Erskine believes that political comedy is more important than ever right now.

“I go back all the time to Jon Stewart’s first show after 9/11 and how he was able to make people laugh after one of the worst days in our country’s history,” she said. “It will always be important to be able to laugh at the absurdity of these people in power.”

Watch Erskine get serious with Nightly.

Nighty video player with Renuka Rayasam and Blaire Erskine

A message from the SEIU:

President Biden’s plan to invest $400 billion in essential care infrastructure is a commitment to America’s future. It means millions of good union jobs for women of color and immigrant workers. It means accessible and affordable home care for all families — so our parents, grandparents and people with disabilities can live at home with dignity and independence. It means thriving, resilient communities.

Congress must meet the president’s commitment to invest in care infrastructure and care workers as a cornerstone of the American economy. Learn more and join us!

 

Did someone forward this email to you? Sign up here.

 

Follow us on Twitter

Renuka Rayasam @renurayasam

Chris Suellentrop @suellentrop

Tyler Weyant @tweyant

Myah Ward @myahward

 

FOLLOW US


 POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA





Friday, March 12, 2021

POLITICO NIGHTLY: A big challenge for Biden’s big vax promise

 


 
POLITICO Nightly logo

BY RENUKA RAYASAM

Presented by Brilliant

With help from Myah Ward

THE TEXAS VACCINE MESS — President Joe Biden is expected to promise that every American adult will be eligible for a Covid-19 vaccine by May 1 in a primetime speech tonight. The U.S. is not Israel or the Seychelles, which lead the world in distributing shots, but it’s ahead of most other nations — including European countries that have been far more successful at tamping down Covid spread.

Yet the country’s federalist, 50-state approach to vaccine distribution — a system that Biden inherited when he became president — has led to starkly different vaccination rates around the country.

Texas has one of the country’s slowest moving vaccination campaigns: About 16 percent of Texans have gotten one dose of a Covid vaccine. About half a dozen states — including Alaska, New Mexico, South Dakota, North Dakota, Connecticut and Rhode Island — have vaccinated about a quarter of their populations. Nearly 19 percent of Americans have been vaccinated nationwide.

Within those states, wide disparities exist among who has been vaccinated. The people who need it the most might not necessarily be getting a shot, something Biden will promise to fix tonight by shipping more vaccines to community health centers, pharmacies and federally run vaccination sites.

But nowhere are the disparities as pronounced as in Texas, a state that as of Wednesday no longer has Covid restrictions or a mask mandate.

“Texas is very much an outlier,” said Lawrence Gostin, a global health law professor at Georgetown who is tracking the nationwide vaccine rollout. By not prioritizing poor and minority communities, Texas has created a profoundly unequal and chaotic system, he said. “As long as there is vaccine scarcity, Texas’s approach will be unfair.”

Most states are using data from the CDC’s vulnerability index to send vaccines to the places with the biggest need, which includes people who are at highest risk of dying from Covid (such as the elderly) or at highest risk of contracting Covid (such as grocery store workers). Rhode Island, for example, set aside vaccines for towns with the highest Covid rates. That approach made low-income Central Falls one of the state’s most vaccinated towns.

Texas, however, is distributing doses to providers in its 254 counties largely based on their overall population. It’s also prioritizing big health care systems. That’s led to tech-savvy people with cars and time to travel getting vaccinated before others who are at higher risk.

At one point at the end of January, when Texas was six weeks into its Covid vaccine rollout, several rural hospitals had yet to receive a single dose, according to Don McBeath at the Texas Organization of Rural & Community Hospitals. They couldn’t vaccinate their health care workers, even though they were in the highest priority tier.

The distribution can seem arbitrary: Rural Baylor County, which has less than 4,000 residents and is near the Oklahoma border, had the highest vaccination rate in the country at the time.

Even now as the state continues to get more doseswide disparities exist throughout the state. Bigger cities are getting more doses — there are now three FEMA vaccine distribution sites in Houston and the Dallas area — but they have a lot more people in need. People in smaller towns without a health care provider or pharmacy don’t have a local source of supply.

There is an acute dearth of vaccines in Black communities, Texas State Senator Borris Miles said. Black Texans, about 13 percent of the state’s population, have gotten 6 percent of vaccine doses in the state, when race is tracked.

Hispanics, about 40 percent of the state’s population, have gotten less than 20 percent of the doses.

Chris Van Deusen, a spokesperson for the Texas health department defended the state’s approach of distributing doses based on population and providers, arguing it is an efficient way to distribute limited vaccine supply. The state’s expert vaccine allocation panel has “discussed the possibility of some weighting by various vulnerability metrics,” he added.

But next week the imbalance will become even biggerAll Texans older than 50 will be eligible for the Covid vaccine starting Monday, even though not everyone in the initial priority populations have been vaccinated, another departure from federal guidance.

In other words, the state is expanding its vaccine pool to still more people who face lower risks — people who work from home, for example — while teachers, the elderly, factory workers and other vulnerable groups are still waiting.

Welcome to POLITICO Nightly. I hope more people will join me on my silent campaign for more essential-oil-free skincare. Reach out with news and tips at rrayasam@politico.com, or on Twitter at @renurayasam.

 

A message from Brilliant:

Start learning with Brilliant and develop the problem-solving skills needed for a STEM career. Learn More

 
FIRST IN NIGHTLY

BIDEN’S COVID WHISPERER — When Biden wanted to know more about his administration’s plan to relax safety guidelines for vaccinated Americans, he turned to Anthony Fauci.

During a meeting last Friday evening in the Oval Office, Fauci, Biden’s chief medical adviser, walked the president through a policy drafted by experts at the Centers for Disease Control and Prevention. It wasn’t that Biden didn’t trust the CDC or its director, Rochelle Walensky, or value their input. But as with other major policy announcements, the president turned to his old friend Fauci for a rundown.

The straight-talking infectious disease expert has developed an increasingly close relationship with the president, who now leans on Fauci more than any other health official to guide his pandemic response, according to three senior officials with knowledge of Biden’s thinking.

Through dinners and White House conversations, the pair has built on a connection that began early in the Obama administration, during the scramble to respond to the H1N1 swine flu pandemic, Sarah OwermohleErin Banco and Adam Cancryn write.

 

SUBSCRIBE TO “THE RECAST” TO JOIN AN IMPORTANT CONVERSATION: Power dynamics are changing. “Influence” is changing. More people are demanding a seat at the table, insisting that all politics is personal and not all policy is equitable. “The Recast” is our new twice-weekly newsletter that breaks down how race and identity are recasting politics, policy and power in America. And POLITICO is recasting how we report on this crucial intersection, bringing you fresh insights, scoops, dispatches from across the country and new voices that challenge “business as usual.” Don’t miss out on this important new newsletter, SUBSCRIBE NOW. Thank you to our sponsor, Intel.

 
 
FROM THE HEALTH DESK

RELIEF FOR THE LONG HAUL — After months of battling symptoms, some Covid long haulers are finally finding relief.

The evidence so far is only anecdotal, but some patients have reported improved symptoms after getting vaccinated. There was concern that long haulers would face worsened symptoms after getting the shot — a fear that’s kept some long Covid patients from getting vaccinated at all — but so far Aruna Subramanian, a professor of infectious diseases at Stanford University, hasn’t seen any cases like that. And a few of her patients have reported feeling better since inoculation.

More than 12,000 members discuss their symptoms and ask questions about vaccinations in a Covid long haulers group on Facebook. Some members shared their experiences with Nightly’s Myah Ward.

Screenshot of Covid long haulers Facebook group

Amanda Finley, of Kansas City, Mo., and the 44-year-old founder of the Facebook group, wondered if she’d made the right choice after getting her first dose of the Moderna vaccine. Her long haul symptoms — chronic fatigue, severe headaches, vomiting, shortness of breath, elevated heart rate (the list goes on) — hit her even harder. She said she didn’t leave her bed for three days. But after a week, these symptoms faded. She said she could breathe again and walk up the stairs without feeling depleted. Finley got her second dose Monday and said she is still feeling great. “Not ashamed to admit that I cried,” she said.

Finley added that she’s trying to pace herself and not get too excited, though she plans to take her son to the park next week for the first time in a year.

One patient had a lingering headache that finally subsided after her first dose of the Pfizer vaccine. Her brain fog cleared up a few days later, she said, and her eyes are less red. She still has chest tightness, but she said she feels like the shot “jump-started my stalled recovery.”

Another woman had two strokes after having Covid last March. She got her first shot on Feb. 25. “For the first time in a year, I actually feel good,” she said. “I think I might actually survive this. I’m planning to take a trip as soon as I get that second shot.”

While it’s understood that long haulers are facing systemic inflammation due to a hyper-activated immune system, research on the phenomenon is still thin. Akiko Iwasaki, a Yale immunologist, has proposed three potential mechanisms for what might be causing long Covid cases.

One possibility is that patients may have a viral reservoir where the virus accumulates and persists. Or it could be a “viral ghost” — fragments of the virus like the spike protein that linger post-infection and continue to stimulate the immune system. The third mechanism could be an ongoing autoimmune response induced by the initial infection, Iwasaki wrote in a blog post last week.

Research has supported each of these mechanisms, Iwasaki said, and it’s possible patients are battling varying degrees of all three — and that each could benefit from a vaccine.

If a long hauler is dealing with a viral reservoir, the vaccine-induced immune cells would attack infected cells to eliminate it. Vaccine-induced immunity may also be able to eliminate the lingering “viral ghosts” associated with the spike protein. For the autoimmune response, the vaccine could potentially divert the cells causing this long-term response in patients — the idea being that the immune cells responsible for attacking a new foriegn body may shift attention to the new antigen introduced by the vaccine.

“It is not clear for how long,” Iwasaki said

As with everything Covid-related, the next step is more research. A trial with long haulers and vaccines could tell researchers not only what is causing long Covid, but which therapies would work best for treatments.

WHAT'D I MISS?

Nightly video player of military leaders taking issue with Tucker Carlson

— Military leaders thrash Tucker Carlson after comments about female troops: Senior military officials are condemning the Fox News host for saying this week that Biden is making a “mockery” of the armed forces through efforts to recruit and keep women in the service.

— Whitmer suggests double standard for Dem, GOP politicians on misconduct allegations: “Is there a different standard for different sides of the aisle? We just had a president who lasted all four years with numerous allegations against him, so far as rape. No one on his own side of the aisle was making observations about whether or not he should stay in office,” Michigan Gov. Gretchen Whitmer said during a POLITICO Live event. “So is there a different standard? I guess one could conclude that.”

— Novavax vaccine shown highly effective against severe Covid: Novavax’s coronavirus vaccine is more than 96 percent effective against the original virus and prevents severe Covid-19 illness entirely, the pharmaceutical company announced today.

— Senate advances Becerra nomination for HHS secretary: A divided Senate advanced Xavier Becerra’s nomination to lead HHS after Maine Republican Susan Collins joined all of the chamber’s Democrats to support a confirmation vote.

— House passes bill to expand gun sale background checks: Democrats are making a new push to enact the first major new gun control laws in more than two decades — starting with stricter background checks.

— Capitol riot suspects held in D.C. are in “restrictive housing”: All suspects detained in Washington, D.C., on charges stemming from the Jan. 6 siege of the Capitol are being treated as “maximum security” prisoners and are held in “restrictive housing,” District officials revealed this week.

 

A message from Brilliant:

Advertisement Image 

 
ASK THE AUDIENCE

Nightly asks you: What is something you postponed in 2020 that you’re planning on doing in 2021? Send us your answer through the form, and we’ll include select answers in a future edition.

THE GLOBAL FIGHT

ANOTHER OXFORD/ASTRAZENECA STUMBLE — Countries across Europe are suspending — some fully, some partially — the rollout of the Oxford/AstraZeneca jab after reports of blood clotting after vaccination.

There have been several deaths from clotting, but health authorities have stressed there’s no indication of a link to vaccination. Still, Austria, Denmark, Estonia, Lithuania, Luxembourg, Latvia and Italy, as well as non-EU Norway and Iceland, have suspended the rollout of at least some Oxford/AstraZeneca batches as a precautionary measure.

Denmark launched more extreme measures today when it paused the entire rollout of Oxford/AstraZeneca vaccines. Norway and Iceland followed suit and halted all distribution of the jab.

MORE ON VAX PASSPORTS — China’s doing them. Europe’s considering them. But they could amplify global inequities. In the latest POLITICO DispatchCarmen Paun breaks down the pros and cons of vaccine passports.

Play audio

Listen to the latest POLITICO Dispatch podcast

 

FIND OUT THE LATEST WHISPERS FROM THE WEST WING: Add Transition Playbook to your daily reads to find out what's really happening inside the West Wing, who really has the president's ear, and get the latest scoop from inside cabinet departments and agencies. Track the people, policies and emerging power centers of the Biden administration. Don’t miss out. Subscribe today.

 
 
NIGHTLY NUMBER

43

The number of Democrats in the New York state Assembly who have called for Gov. Andrew Cuomo to resign or be impeached . Those members, coupled with the chamber’s 43 Republicans, add up to 86 — 10 more than would be required to impeach the governor.

PARTING WORDS

MEXICO’S MARIJUANA MOMENT — Mexico is on the verge of creating the world’s largest legal marijuana market, a move that could pressure Biden to embrace weed, too, Paul Demko and Ximena Bustillo write.

Mexico’s Chamber of Deputies passed landmark legislation today. The Senate is expected to back the bill in the coming days.

“It’s historic,” said Luis Armendáriz, a cannabis attorney with the Hoban Law Group who works with companies that are looking to enter the Mexican market. “You have the end of prohibition of more than 100 years.”

President Andrés Manuel López Obrador, whose party strongly backs the proposal, is expected to sign the bill, sandwiching the U.S. between the world’s two biggest legal marijuana markets.

 

A message from Brilliant:

Start learning with Brilliant and develop the quantitative skills needed for a STEM career. Brilliant's interactive problem-solving and guided lessons will lead you to mastery. Learn More

 

Did someone forward this email to you? Sign up here.

 

Follow us on Twitter

Renuka Rayasam @renurayasam

Chris Suellentrop @suellentrop

Tyler Weyant @tweyant

Myah Ward @myahward

 

FOLLOW US


POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA





Trump admits humiliating defeat in pool debacle

                                                     LOTS OF POSTS IGNORED BY BLOGGER..... OR REMOVED ON THEIR WHIM! ALL POSTS ARE AVAILABLE...